Splash Corporation Maxi-Peel Exfoliant product recall (2020-05-22)
- Starting date:
- May 22, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73221
Last updated: 2020-05-28
Summary
-
Product:
- Maxi-Peel Exfoliant Solution #1;
- Maxi-Peel Exfoliant Solution #2;
- Maxi-Peel Exfoliant Solution #3
- Maxi-Peel Exfoliant Solution #1;
- Maxi-Peel Exfoliant Solution #2;
- Maxi-Peel Exfoliant Solution #3
Reason
Product sold without market authorization (DIN) in Canada. Product contains tretinoin that is listed on the prescription drug list.
Depth of distribution
Wholesalers, Retailers
Affected products
A. Maxi-Peel Exfoliant Solution #1
DIN, NPN, DIN-HIM
No market authorization
Dosage form
Solution
Strength
- Tretinoin 0.010%
- Hydroquinone 2%
Lot or serial number
All lots
Companies
- Recalling Firm
-
New Almanic International Ltd.
114 Norfinch Dr Unit 5
North York
M3N 1X1
Ontario
CANADA
- Marketing Authorization Holder
-
N/A
B. Maxi-Peel Exfoliant Solution #2
DIN, NPN, DIN-HIM
No market authorization
Dosage form
Solution
Strength
- Tretinoin 0.025%
- Hydroquinone 2%
Lot or serial number
All lots
Companies
- Recalling Firm
-
New Almanic International Ltd.
114 Norfinch Dr Unit 5
North York
M3N 1X1
Ontario
CANADA
- Marketing Authorization Holder
-
N/A
C.Maxi-Peel Exfoliant Solution #3
DIN, NPN, DIN-HIM
No market authorization
Dosage form
Solution
Strength
- Tretinoin 0.025%
- Hydroquinone 2%
Lot or serial number
All lots
Companies
- Recalling Firm
-
New Almanic International Ltd.
114 Norfinch Dr Unit 5
North York
M3N 1X1
Ontario
CANADA
- Marketing Authorization Holder
-
N/A
Related AWRs
